SIASUN(SZ:300024) Jin Rong Jie·2025-12-04 04:20Market Overview - The Hong Kong stock market showed mixed performance with the Hang Seng Index rising by 0.19% to 25,809.45 points, while the Hang Seng Tech Index increased by 0.58% to 5,567.23 points [1] - Major tech stocks exhibited divergent trends, with Alibaba down 0.26%, Tencent down 0.41%, and JD.com down 0.35%, while Xiaomi rose by 2.88% and Meituan increased by 2.03% [1] - The semiconductor sector saw significant gains, with InnoCare Pharma rising over 4% and the robotics sector led by Sanhua Intelligent Controls surging by 9% [1] Company News - InnoCare Pharma (02577.HK) announced a strategic cooperation agreement with Onsemi to accelerate the GaN industry ecosystem, potentially generating hundreds of millions in GaN sales in the coming years [2] - Agile Group (03383.HK) reported a pre-sale amount of approximately 8.08 billion, a year-on-year decline of 45.2% [3] - Jinke Property (01862.HK) recorded a contract sales amount of about 876 million, down 54.1% year-on-year [4] - Chint New Energy (00182.HK) is collaborating with insurance capital to establish a partnership worth 1.811 billion, aiming to promote renewable energy investments [4] - China Aluminum International (02068.HK) won a contract for a new electrolytic aluminum project valued at 3.03 billion [4] - Stone Pharmaceutical Group (01093.HK) received clinical trial approval for a selective 5-HT2A receptor agonist in the U.S. [5] - Fosun Pharma (02196.HK) obtained clinical trial approval for its subsidiary's FXS887 tablets [6] - Zai Lab (02617) had its Tazemetostat tablets included in the priority review list by the National Medical Products Administration [7] - Diligent Pharma (06996) received approval for its drug in Hong Kong for treating multiple myeloma and diffuse large B-cell lymphoma [7] - Kaisa Group (01813) postponed its liquidation hearing to December 8 [8] Institutional Insights - CCB International noted that internal demand policies are expected to drive market attention towards the upcoming "opening red" expectations, with a potential for a year-end rally in December [9] - Guotai Junan Securities indicated that the recent adjustments in the Hong Kong market may open up space for growth in 2026, with significant net inflows from southbound funds [9] - Everbright Securities highlighted that while there is considerable room for growth compared to previous bull markets, the current market may lack strong catalysts in the short term, leading to a period of consolidation [9]